Showing results (471-480 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|August 5, 2021
Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinomaEleanor Paul, Gerasimos Konidaris, Shannon Cope, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Web-based patient portal use and medication overlap from VA and private-sector pharmacies among older veteransKevin T Stroupe, Kim Nazi, Timothy P Hogan, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemiaRena M Conti, William V Padula, Russell V Becker, et al.Journal of Managed Care & Specialty Pharmacy|August 2, 2021
Limited role of patient input in specialty drug coverage policiesBrittany D'Cruz, Jennifer S Graff, Ari D Panzer, et al.Journal of Managed Care & Specialty Pharmacy|August 24, 2022
Impact of pharmacy services on time to elexacaftor-tezacaftor-ivacaftor initiationLauren Roder, Michelle Simonsen, Lindsey Fitzpatrick, et al.Journal of Managed Care & Specialty Pharmacy|August 24, 2022
Characterizing health plan evidence review practicesAri D Panzer, Daniel E Enright, Jen Graff, et al.Journal of Managed Care & Specialty Pharmacy|December 2, 2021
Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United StatesXinke Zhang, Daniel C Beachler, Elizabeth Masters, et al.Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) studyAnirban Basu, Carmela Benson, Ibrahim Turkoz, et al.Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Perceptions of prior authorization by use of electronic prior authorization software: A survey of providers in the United StatesStephen G Salzbrenner, Carrie McAdam-Marx, Maxwell Lydiatt, et al.Journal of Managed Care & Specialty Pharmacy|September 20, 2022
Real-world use patterns of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) among patients with heart failure within a large integrated health systemBrendan J Kim, Cheng-Wei Huang, Joanie Chung, et al.Pageof 185